Difference between revisions of "Carboxyatractyloside"
From Bioblast
Garcia Luiz (talk | contribs) |
|||
| Line 3: | Line 3: | ||
|description='''Carboxyatractyloside''', Cat, is a highly selective and potent inhibitor of the [[adenine nucleotide translocator]] (ANT). Cat stabilizes the nucleoside binding site of ANT on the cytoplasmic (positive) side of the inner membrane and blocks the exchange of matrix ATP and cytoplasmic ADP. It causes stabilization of the ''c'' conformation of ANT leading to permeability transition pore (PTP) opening, loss of mitochondrial membrane potential, and apoptosis. | |description='''Carboxyatractyloside''', Cat, is a highly selective and potent inhibitor of the [[adenine nucleotide translocator]] (ANT). Cat stabilizes the nucleoside binding site of ANT on the cytoplasmic (positive) side of the inner membrane and blocks the exchange of matrix ATP and cytoplasmic ADP. It causes stabilization of the ''c'' conformation of ANT leading to permeability transition pore (PTP) opening, loss of mitochondrial membrane potential, and apoptosis. | ||
|info=[[MiPNet03.02]] | |info=[[MiPNet03.02]] | ||
}} | |||
{{MitoPedia concepts}} | |||
{{MitoPedia methods}} | |||
{{MitoPedia O2k and high-resolution respirometry}} | |||
{{MitoPedia topics | |||
|mitopedia topic=Inhibitor | |||
}} | }} | ||
__TOC__ | __TOC__ | ||
| Line 39: | Line 45: | ||
:::: '''Preparation of 0.5 mM solution''' (dissolved in H<sub>2</sub>O) for '''0.5-mL O2k-chamber''': | :::: '''Preparation of 0.5 mM solution''' (dissolved in H<sub>2</sub>O) for '''0.5-mL O2k-chamber''': | ||
::::# Take 50 µL of the | ::::# Take 50 µL of the 2 mM stock solution. | ||
::::# Add 150 µL H<sub>2</sub>O. | ::::# Add 150 µL H<sub>2</sub>O. | ||
| Line 51: | Line 57: | ||
» [[Talk:Carboxyatractyloside]] | » [[Talk:Carboxyatractyloside]] | ||
Revision as of 13:34, 9 November 2020
- high-resolution terminology - matching measurements at high-resolution
Carboxyatractyloside
Description
Carboxyatractyloside, Cat, is a highly selective and potent inhibitor of the adenine nucleotide translocator (ANT). Cat stabilizes the nucleoside binding site of ANT on the cytoplasmic (positive) side of the inner membrane and blocks the exchange of matrix ATP and cytoplasmic ADP. It causes stabilization of the c conformation of ANT leading to permeability transition pore (PTP) opening, loss of mitochondrial membrane potential, and apoptosis.
Abbreviation: Cat
Reference: MiPNet03.02
MitoPedia topics: Inhibitor
Application in HRR
- Cat: Carboxyatractyloside (carboxyatractyloside potassium salt from Xanthium sibiricum, C31H44O18S2*Kx); Sigma C 4992, 2 mg, store at -20 °C; FW = 802.99 (free acid basis); Alternative source: Merck 216201-5MG (Calbiochem, Carboxyatractyloside potassium salt from Xanthium sibiricum, C31H43O18S2K3*3H2O), 5 mg, store at -20 °C, FW = 939.1).
- Caution: Chemicals stored in the fridge or freezer should be allowed to reach room temperature before opening. Very toxic!
- Preparation of 2 mM stock solution (dissolved in H2O) for 2-mL O2k-chamber:
- For a vial with 2 mg of carboxyatractyloside: dissolve in 1065 µL H2O.
- Divide into 100 µL aliquots.
- Store at -20 °C.
- » O2k manual titrations » MiPNet09.12 O2k-Titrations
- Titration volume (2-mL O2k-chamber): 1-5 µL using a 10 µL Hamilton syringe.
- Final concentration: 1-5 µM.
- Preparation of 0.5 mM solution (dissolved in H2O) for 0.5-mL O2k-chamber:
- Take 50 µL of the 2 mM stock solution.
- Add 150 µL H2O.
- » O2k manual titrations » MiPNet09.12 O2k-Titrations
- Titration volume (0.5-mL O2k-chamber): 1-5 µL using a 10 µL Hamilton syringe.
- Final concentration: 1-5 µM.
- Comment: Cat is considered to be much more specific than Atractyloside (Atr), and the effective concentration required is much much lower (µM). With Atr, a very high concentration (mM) is required for full inhibition. Cat appears to be little permeable to intact cells and can thus only be applied in permeabilized cells and tissues or in isolated mitochondria (Ruas 2016 PLOS_ONE).
» Talk:Carboxyatractyloside
